Thus, with low adiponectin levels in obesity, the CD40L-related platelet functions may be shifted from pro-oncogenic to anti-neoplastic and may thus be hindering the positive association of platelets with lung cancer risk. Here, ADIPOQ is linked to obesity disorder.